Clinical trial
Complementary Therapies for the Reduction of Side Effects During Chemotherapy…
NCT00160901 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00160901 |
|---|---|
| Title | Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer |
| Official title | Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg |
| Lead sponsor | Heidelberg University, Other |
| Collaborators | Hector-Stiftung Cefak KG, Kempten Ursapharm, Saarbrücken Schwabe-Wenex International Ltd Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | two complex naturopathic add-on therapies, leaflet 5-a-day |
| Enrollment | 150 |
| Start date | Aug 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 19, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: